ICMR transfers three Indigenous Medical Technologies

The Indian Council of Medical Research (ICMR) participated in the national programme ‘विज्ञान–Tech’, organised on the occasion of National Technology Day 2026 at BRIC–National Institute of Immunology (NII), New Delhi. Coordinated by the Office of the Principal Scientific Adviser (PSA) in collaboration with the Department of Biotechnology (DBT), the programme reflected a Whole-of-Government approach, bringing together 14 Scientific Ministries and Departments to celebrate India’s scientific excellence and technological advancements.

The event was graced by the Union Minister of State (Independent Charge) for Science & Technology, Dr. Jitendra Singh, who inaugurated the national technology exhibition and interacted with innovators and exhibitors. Prof. Ajay Kumar Sood, Principal Scientific Adviser to the Government of India and Dr Rajiv Behl, Secretary, Department of Health Research and DG ICMR, was also present on the occasion.

As part of its showcase, ICMR exhibited six high-impact indigenous technologies spanning the Biopharma, Health, and Bioindustrial & Green Chemicals sectors. These included Covaxin, the COVID Kavach ELISA Kit, a CRISPR-Cas-based TB Detection System, the Nipah Point-of-Care Assay, a Diagnostic ELISA Kit for Dengue Detection, and a Biolarvicide for Mosquito Control.

In addition, 25 promising technologies and innovations developed by various ICMR institutes were featured in the official compendium released during the event. These innovations highlighted ICMR’s significant contributions in diagnostics, medical devices, digital health, disease surveillance, and translational research, reinforcing its commitment to addressing national health priorities through indigenous research and innovation.(UPDATED ON 11TH MAY 2026)